TeleCareSpot Review
Best for: Flat-priced, LegitScript-verified compounded semaglutide or tirzepatide with broad state coverage
TeleCareSpot is a telehealth weight-loss platform offering doctor-prescribed compounded GLP-1s with flat, all-inclusive monthly pricing: compounded semaglutide at $299/month and tirzepatide at $399/month (all doses), plus oral tirzepatide and phentermine. Licensed US physicians review your intake, and an optional DNA-calibrated approach tailors your dose to your metabolism. It carries verifiable LegitScript certification and HIPAA compliance, ships free, and is cancel-anytime. Available in 47 states and DC (not AK, MS, or NJ); compounded meds are not FDA-approved and the pharmacy is unnamed.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
TeleCareSpot stands out for its medical oversight and pharmacy verification.
TeleCareSpot at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Oral tirzepatide
- Starting price
- $299/mo ($299/month flat, all doses; everything included, no hidden fees. Separate consult fee credited toward the package if approved.)
- What's included
- Medication · Consult · Shipping
- Availability
- 48 states
- FDA status
- No FDA warning letter on record
How we scored TeleCareSpot
Each dimension is scored algorithmically from TeleCareSpot’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.6/10At $299/mo, TeleCareSpot runs about 77% above the $169 median for GLP-1 providers.
Effectiveness25%
9.3/10TeleCareSpot offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
8.5/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
9.2/10Key details fully confirmed by our editors; no FDA warning letters on file (last checked 2026-06-27).
Accessibility10%
9.4/10TeleCareSpot treats patients in all 50 states.
Support10%
7.0/10TeleCareSpot provides standard clinician follow-up; no extended coaching or community program is disclosed.
How we verified this TeleCareSpot review
Last checked 2026-06-27- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
GLP-1 medications TeleCareSpot offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
$299/month flat, all doses; everything included, no hidden fees. Separate consult fee credited toward the package if approved.
$399/month flat, all doses; everything included. Oral tirzepatide and phentermine also offered (price at intake).
Ready to get started?
Plans and promotions change often — check TeleCareSpot's current pricing and active discounts before you decide.
What we like
- Flat, all-inclusive monthly pricing with no hidden fees — compounded semaglutide $299/month and tirzepatide $399/month, all doses included
- Verifiable LegitScript certification (seal ID 45936855) plus HIPAA compliance and licensed US physicians
- Multiple options: compounded semaglutide, tirzepatide, oral tirzepatide, and phentermine
- DNA-calibrated dosing option that tailors the GLP-1 dose to how you metabolize it
- Broad coverage in 47 states and DC, with free shipping and cancel-anytime plans
- Fast online flow: assessment, licensed-doctor review, and delivery within days
Watch-outs
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Not available in Alaska, Mississippi, or New Jersey
- The compounding pharmacy partner is not named
- A separate weight-loss consultation fee applies (credited toward your medication package if approved)
- Trustpilot rating and review counts (4.9, 14,000+) are self-stated on the site
Is TeleCareSpot worth it? Our verdict
TeleCareSpot positions itself around one thing: Flat-priced, LegitScript-verified compounded semaglutide or tirzepatide with broad state coverage. It runs $299/month — a premium to the category, so the extras need to justify it. Its standout is a needle-free oral option, which very few providers offer.
How much TeleCareSpot actually costs
- Compounded semaglutide — $299/month
- Compounded tirzepatide — $399/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so TeleCareSpot's standing rate sits at the premium end.
Medications: what TeleCareSpot prescribes
TeleCareSpot prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
TeleCareSpot's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who TeleCareSpot is best for — and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option.
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
TeleCareSpot treats patients in all 50 states. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
TeleCareSpot costs more than the budget end of the market, so it makes the most sense if its specific extras — the oral option especially matter to you. If they don't, you can likely get the same medication for less elsewhere.
Ready to start with TeleCareSpot?
Starting at $299/month. See current pricing and start your free consultation.
Alternatives to TeleCareSpot
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this TeleCareSpot review:
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Ready to start with TeleCareSpot?
Starting at $299/month. See current pricing and start your free consultation.